Andersson Svärd, Agnes http://orcid.org/0000-0002-6838-7382
Kaur, Simranjeet
Trôst, Kajetan
Suvitaival, Tommi
Lernmark, Åke
Maziarz, Marlena
Pociot, Flemming
Overgaard, Anne Julie
,
Funding for this research was provided by:
Anna och Edwin Bergers Stiftelse
Filip Lundbergs Stiftelse
Blekinge Diabetesförening: Fogelstöms Fond
Fredrik och Ingrid Thurings Stiftelse
H.K.H. Kronprinsessan Lovisas Förening för Barnasjukvård
Kungliga Fysiografiska Sällskapet i Lund
LIONS Research Fund Skåne
Maggie Stephens Stiftelse
Stiftelsen Samariten
Sydvästra Skånes Diabetesförening
Stiftelsen till minne av Personalföreningarna i Holmia Försäkring AB
Sven Mattssons Stiftelse
Svenska Diabetesstiftelsen
Vetenskapsrådet (Dnr 2016-01792)
Barndiabetesfonden
Tage Blüchers Stiftelse för medicinsk forskning
The Gyllenstiernska Krapperup’s Foundation
Wera Ekströms Stiftelse för Pediatrisk Forskning
The Strategic Research Area Exodiab (Dnr 2009-1039)
The Swedish Foundation for Strategic Research (Dnr IRC15-0067)
The Juvenile Diabetes Research Foundation (2-SRA-2016-290-S-B, 3-PDF-2016-180-A-N)
Lund University
Article History
Received: 19 December 2019
Accepted: 25 September 2020
First Online: 8 October 2020
Compliance with ethical standards
:
: The authors declare no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the Ethical Standards of the Institutional and/or National Research Committee (the Regional Ethical Review Board in Lund: Dnr 2009/244, Dnr 2014/196 and Dnr 2015/861) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The DiPiS study, initiated in 2000, complied with ethical standards and did not pose a significant risk for the research subjects. Blood sampling was preceded by EMLA cream to reduce pain.
: Informed consent was obtained from the parents of the subjects to participate in the present cross-sectional follow up investigation.